You wish to develop a new pharmaceutical that stimulates the production of Protein Kinase A. To do this you will need to combine two different compounds targeting the norepinephrine system. Which combination would maximally simulate Protein Kinase A? beta receptor antagonist + sigma 2 receptor agonist beta receptor agonist + sigma 2 receptor agonist beta receptor antagonist + sigma 2 receptor antagonist beta receptor agonist + sigma 2 receptor antagonist
Added by Stephen H.
Step 1
Norepinephrine is a neurotransmitter that binds to beta receptors, which are G protein-coupled receptors. When norepinephrine binds to beta receptors, it activates adenylyl cyclase, leading to the production of cyclic AMP (cAMP). cAMP, in turn, activates Protein Show more…
Show all steps
Your feedback will help us improve your experience
Sri K and 61 other Biology educators are ready to help you.
Ask a new question
Labs
Want to see this concept in action?
Explore this concept interactively to see how it behaves as you change inputs.
Key Concepts
Recommended Videos
The binding of epinephrine to a G protein-coupled receptor causes adenylyl cyclase to produce large amounts of: inositol 3-phosphate phospholipase C protein kinase C protein kinase A cAMP An inhibitor of which of the following could be used to block the activation of protein kinase A? steroid hormone receptors phospholipase C serine/threonine kinases adenylyl cyclase
Sri K.
You discover a drug that binds to and antagonizes adenylyl cyclase. You would expect this drug to lead to ____________. A. downregulation of the G protein-coupled receptor (GPCR) B. increased concentration of cAMP in the cytoplasm C. influx of Ca 2+ in the cytoplasm D. activation of protein kinase C (PKC) E. decreased phosphorylation of protein kinase A (PKA)
Bryan V.
Receptor tyrosine kinases (you may want to review this family of receptors) have a ligan-binding domain on the outside of a cell and a kinase domain on the inside of the cell. Select all tru statements: (SELECT ALL THAT APPLY) A- Antibodies can be used to block the ligand-binding domain B- Antibodies can be used to block the activity of the kinase domain C- ATP and its analogs bind the kinase domain D- The signal (ligand binding) is often transduced through dimerization of the receptor E- Upon ligand binding the receptors localize to the nucleus to change gene expression F- Because they have extracellular domains, hydrophilic drugs can easily target these receptors
Shaiju T.
Recommended Textbooks
Biology for AP Courses
Objective Biology for NEET
Introduction to General, Organic and Biochemistry
Transcript
Watch the video solution with this free unlock.
EMAIL
PASSWORD